Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NewGenIvf (NIVF) Cash & Equivalents: 2022-2025

Historic Cash & Equivalents for NewGenIvf (NIVF) over the last 4 years, with Q3 2025 value amounting to $295.3 billion.

  • NewGenIvf's Cash & Equivalents changed N/A to $295.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $295.3 billion, marking a year-over-year change of. This contributed to the annual value of $457740.0 for FY2024, which is 74603.73% up from last year.
  • According to the latest figures from Q3 2025, NewGenIvf's Cash & Equivalents is $295.3 billion.
  • In the past 5 years, NewGenIvf's Cash & Equivalents ranged from a high of $295.3 billion in Q3 2025 and a low of $27556.0 during Q4 2022
  • Moreover, its 4-year median value for Cash & Equivalents was $457740.0 (2024), whereas its average is $59.1 billion.
  • In the last 5 years, NewGenIvf's Cash & Equivalents surged by 9634.2% in 2023 and then surged by 74603.73% in 2024.
  • NewGenIvf's Cash & Equivalents (Quarter) stood at $27556.0 in 2022, then soared by 96.34% to $54104.0 in 2023, then surged by 746.04% to $457740.0 in 2024, then surged by 64510102.3% to $295.3 billion in 2025.
  • Its last three reported values are $295.3 billion in Q3 2025, $1.6 million for Q2 2025, and $457740.0 during Q4 2024.